Wall Street’s major indexes overcame a mixed open and closed higher on Friday, as investors digest monthly inflation data, which came in line with expectations. However, the S&P 500 Health Care Index ...

We recently published a list of 10 Battered Stocks on Friday. In this article, we are going to take a look at where Walgreens ...

A potential Sycamore buyout sounded like good news--until analysts revealed the brutal reality behind the deal.

From Walgreens' breakup to Forever 21's pending bankruptcy, M&A and drama unfold in this week's edition of Deal Dispatch.

Walgreen Boots Alliance (WBA) stock was downgraded to Sell from Hold by Deutsche Bank analysts, the team also cutting its price target to $9 from $11 per share. Julie Hyman and Josh Lipton break down ...

Walgreens Boots (NASDAQ:WBA) fell 4.7% after a report that a Sycamore Partners deal for the drugstore chain is unlikely to have much of a premium. Sycamore is closing in on a deal for Walgreens ...

The deal is not yet finalized. Other news includes: tariffs on the pharmaceutical industry and what it means for medicine; Pfizer putting emphasis on merit in the face of DEI overhaul; and more.

Explore the uncertain future of Walgreens Boots Alliance (WBA) amid buyout hurdles, litigation risks & industry challenges.

The deal hype started in early-December, when the Wall Street Journal reported Walgreens was in talks to sell itself to Sycamore Partners. Read: Walgreens' stock could see its best day ever. Is a ...

Sycamore Partners is planning a three-way split of Walgreens Boots Alliance if a deal to take the struggling pharmacy chain ...

Deutsche Bank downgraded Walgreens Boots Alliance (WBA) to Sell from Hold with a price target of $9, down from $11. The firm says the reports ...

Boots’ prospective buyer Sycamore Partners is planning to separate the UK retail pharmacy business from its US and healthcare ...